Follow-up of pregnant women exposed to chicken pox: An audit of relationship between level of antibody and development of chicken pox

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 10, 2011, Pages 1193-1200

  Boxall, E H ^a   Maple, P A C ^a   Rathod, P ^a   Smit, E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS DNA;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHICKENPOX; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLUOROIMMUNOASSAY; FOLLOW UP; HUMAN; IMMUNE STATUS; INFECTION PREVENTION; INFECTION SENSITIVITY; LABORATORY TEST; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, VIRAL; CHICKENPOX; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUESTIONNAIRES;

EID: 80054758411     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1211-4     Document Type: Article

References (16)

1. G Enders E Miller J Cradock-Watson I Bolley M Ridehaigh 1994 Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases Lancet 343 1548 1551 7802767 10.1016/S0140-6736(94)92943-2 1:STN:280: DyaK2c3ns1Krtg%3D%3D
2. AL Alkalay JJ Pomerance DL Rimoin 1987 Fetal varicella syndrome J Pediatr 111 320 323 3625399 10.1016/S0022-3476(87)80447-X 1:STN:280: DyaL2szhtV2gsw%3D%3D
3. AJ Daley S Thorpe SM Garland 2008 Varicella and the pregnant woman: prevention and management Aust NZ J Obstet Gynaecol 48 26 33 10.1111/j.1479-828X.2007.00797.x
4. Department of Health, Joint Committee of Vaccination and Immunisation (2006) Immunisation against infectious disease. Stationery Office Books, UK
5. E Miller R Marshall J Vurdien 1993 Epidemiology, outcome and control of varicella-zoster infection Rev Med Microbiol 4 222 230
6. PA Chris Maple A Gunn J Sellwood DWG Brown JJ Gray 2009 Comparison of fifteen commercial assays for detecting varicella zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals J Virol Methods 155 143 149 18996415 10.1016/j.jviromet.2008.09.032 1:STN:280:DC%2BD1M%2FgtlGmuw%3D%3D
7. V Williams A Gershon PA Brunell 1974 Serologic response to varicella-zoster membrane antigens measured by indirect fluorescence J Infect Dis 130 669 672 4372275 10.1093/infdis/130.6.669 1:STN:280: DyaE2M%2Fkt1Wjsg%3D%3D
8. PAC Maple J Breuer G Kafatos S Parker D Brown 2006 Performance of a time resolved fluorescence immunoassay for measuring varicella zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay Clin Vaccine Immunol 13 214 218 16467328 10.1128/CVI.13.2.214-218.2006 1:CAS:528:DC%2BD28Xhs1Gmsbs%3D
9. PAC Maple J Gray K Brown D Brown 2009 Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection J Virol Methods 157 90 92 10.1016/j.jviromet.2008.12.007 1:CAS:528: DC%2BD1MXis1ChsLo%3D
10. PA Maple P Rathod E Smit J Gray D Brown EH Boxall 2009 Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay J Clin Virol 44 9 14 18823815 10.1016/j.jcv.2008.08.012 1:CAS:528:DC%2BD1cXhsFCgs7%2FO
11. SLR McDonald PAC Maple N Andrews, et al. 2011 Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers J Virol Methods 10.1016/jviromet.2010.12.021 21192976
12. E MacMahon LJ Brown S Bexley DC Snashall D Patel 2004 Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study BMJ 329 551 552 15273160 10.1136/bmj.38170.691956.AE
13. CDC (2008) Manual for surveillance of VPD, ch. 17: varicella. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt17-varicella.htm. Accessed 16 March 2011
14. S Hall T Maupan J Seward 2002 Second varicella infections: are they more common than previously thought? Pediatrics 109 1068 1073 12042544 10.1542/peds.109.6.1068
15. A Pinot de Moira WJ Edmunds J Breuer 2006 The cost effectiveness of antenatal varicella screening with post partum vaccination of susceptibles Vaccine 24 1298 1307 16236401 10.1016/j.vaccine.2005.09.028 1:STN:280: DC%2BD28%2FptFSmuw%3D%3D
16. JA Troughton G Crealey V Crawford PV Coyle 2009 Management of varicella contacts in pregnancy: VZIG or vaccination J Clin Virol 46 345 348 19828369 10.1016/j.jcv.2009.09.014 1:CAS:528:DC%2BD1MXhtlyltrfP